FDA’s Patient Engagement Advisory Committee Announces Inaugural Meeting

The FDA’s Patient Engagement Advisory Committee (PEAC) will hold its inaugural meeting in Gaithersburg, Maryland, October 11-12 to discuss how patients, devicemakers, and the FDA can share information.

The nine-member committee will meet “once or twice a year,” the agency says, and the meetings will be open to the public.

Patients can have “unexpected experiences” with a device or clinical trial, and the PEAC will allow patients to share what happened with the device manufacturer and the FDA, said Jeffrey Shuren, CDRH director, and Kathryn O’Callaghan, CDRH assistant director for strategic programs, in a July 25 blog post.